Tinalox 50 mg - 4 mg oral drops sol. met. pump Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

tinalox 50 mg - 4 mg oral drops sol. met. pump

sandoz sa-nv - tilidine hydrochloride hemihydrate 71,583 mg/ml - eq. tilidine hydrochloride 69,444 mg/ml; naloxone hydrochloride hemihydrate 6,111 mg/ml - eq. naloxone hydrochloride 5,556 mg/ml - oral drops, solution - 50 mg/0,72 ml - 4 mg/0,72 ml - tilidine hydrochloride hemihydrate; naloxone hydrochloride hemihydrate - naloxone; n02ax01 tilidine

Valtran 50 mg - 4 mg oral drops sol. dropper cont. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

valtran 50 mg - 4 mg oral drops sol. dropper cont.

pfizer sa-nv - naloxone hydrochloride dihydrate 6,083 mg/ml - eq. naloxone hydrochloride 5,5 mg/ml; tilidine hydrochloride hemihydrate 71,197 mg/ml - eq. tilidine hydrochloride 69,2 mg/ml - oral drops, solution - 50 mg - 4 mg - naloxone hydrochloride dihydrate 6.083 mg/ml; tilidine hydrochloride hemihydrate 71.197 mg/ml - tilidine

Tinalox 50 mg - 4 mg oral drops sol. met. pump Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

tinalox 50 mg - 4 mg oral drops sol. met. pump

sandoz sa-nv - tilidine hydrochloride hemihydrate 71,583 mg/ml - eq. tilidine hydrochloride 69,444 mg/ml; naloxone hydrochloride hemihydrate 6,111 mg/ml - eq. naloxone hydrochloride 5,556 mg/ml - oral drops, solution - naloxone; n02ax01 tilidine

Valtran Retard 100 mg - 8 mg tabl. prol.-rel. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

valtran retard 100 mg - 8 mg tabl. prol.-rel.

pfizer sa-nv - tilidine phosphate 119,86 mg - eq. tilidine hydrochloride 100 mg; naloxone hydrochloride dihydrate 8,8 mg - eq. naloxone hydrochloride 8 mg - prolonged-release tablet - 100 mg - 8 mg - naloxone hydrochloride dihydrate; tilidine phosphate 119.86 mg - tilidine

Valtran Retard 150 mg - 12 mg tabl. prol.-rel. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

valtran retard 150 mg - 12 mg tabl. prol.-rel.

pfizer sa-nv - tilidine phosphate 179,79 mg - eq. tilidine hydrochloride 150 mg; naloxone hydrochloride dihydrate 13,2 mg - eq. naloxone hydrochloride 12 mg - prolonged-release tablet - 150 mg - 12 mg - naloxone hydrochloride dihydrate; tilidine phosphate 179.79 mg - tilidine

Valtran Retard 50 mg - 4 mg tabl. prol.-rel. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

valtran retard 50 mg - 4 mg tabl. prol.-rel.

pfizer sa-nv - tilidine phosphate 59,93 mg - eq. tilidine hydrochloride 50 mg; naloxone hydrochloride dihydrate 4,4 mg - eq. naloxone hydrochloride 4 mg - prolonged-release tablet - 50 mg - 4 mg - naloxone hydrochloride dihydrate; tilidine phosphate 59.93 mg - tilidine

Valoron Capsules Namibia - English - Namibia Medicines Regulatory Council

valoron capsules

pfizer laboratories (pty) ltd - tilidine hydrochloride - capsule - tilidine hydrochloride 50 mg per capsule

Valoron Drops Namibia - English - Namibia Medicines Regulatory Council

valoron drops

pfizer laboratories (pty) ltd - tilidine hydrochloride - opthalmic solution - tilidine hydrochloride 100 mg per ml

VALORON Zimbabwe - English - Medicines Control Authority

valoron

pfizer labs pty ltd - tilidine hydrochloride - solution - 100mg/ml

Prevymis European Union - English - EMA (European Medicines Agency)

prevymis

merck sharp & dohme b.v. - letermovir - cytomegalovirus infections - antivirals for systemic use - prevymis is indicated for prophylaxis of cytomegalovirus (cmv) reactivation and disease in adult cmv-seropositive recipients [r+] of an allogeneic haematopoietic stem cell transplant (hsct).consideration should be given to official guidance on the appropriate use of antiviral agents.